Letermovir is an antiviral active pharmaceutical ingredient used to prevent cytomegalovirus (CMV) infections, particularly in immunocompromised patients such as those undergoing allogeneic stem cell transplants. It is a research compound developed for pharmaceutical manufacturing and supply.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 917389-32-3
Acetamide,N-[9-[[2-(acetyloxy)-1-[(acetyloxy)methyl]ethoxy]methyl]-6,9-dihydro-6-oxo-1H-purin-2-yl]-
antiviral active pharmaceutical ingredient
Isoprinosine
antiviral active pharmaceutical ingredient
Foscarnet
antiviral active pharmaceutical ingredient
Acyclovir alaninate
antiviral active pharmaceutical ingredient
Cefdinir
active pharmaceutical ingredient
Vemurafenib
active pharmaceutical ingredient
Lithium citrate
antidepressant pharmaceutical ingredient
PHENOTHIAZINE
Parent compound for antipsychotic drugs
2-[(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4H-quinazolin-4-yl]acetic acid
FWYSMLBETOMXAG-QHCPKHFHSA-N
COC1=C(C=C(C=C1)C(F)(F)F)N2[C@H](C3=C(C(=CC=C3)F)N=C2N4CCN(CC4)C5=CC(=CC=C5)OC)CC(=O)O